Learn more →
Back to Expert Scholars
clinical / clinicalFrench GI oncology gastric and esophageal

Michel Ducreux

米歇尔·迪克鲁

MD, PhD

🏢Gustave Roussy Cancer Campus(古斯塔夫·鲁西癌症校区)🌐France

Head, Gastrointestinal Oncology胃肠肿瘤科主任

58
h-index
2
Key Papers
2
Awards
2
Key Contributions

👥Biography 个人简介

Michel Ducreux is the head of GI oncology at Gustave Roussy and a leading French contributor to gastric, esophageal, and upper GI cancer clinical trials through the PRODIGE (PROgramme Dedication Investisseurs en Gastro-Enterologie) network. He co-led the ESOPEC trial comparing FLOT versus CROSS neoadjuvant strategies in resectable esophageal cancer, providing European evidence on perioperative chemotherapy versus chemoradiation. Ducreux chairs the UNICANCER GI group and has contributed to ESMO guideline development for gastroesophageal cancers. His translational research focuses on biomarker-driven patient selection for first-line gastric cancer treatment.

Share:

🧪Research Fields 研究领域

gastric cancer France法国胃癌
esophageal cancer chemotherapy食管癌化疗
PRODIGE trialsPRODIGE试验
GI oncology UNICANCERGI肿瘤UNICANCER
oxaliplatin-based regimens奥沙利铂方案

🎓Key Contributions 主要贡献

ESOPEC Trial

Co-led ESOPEC trial comparing FLOT versus CROSS perioperative strategies in esophageal cancer, generating definitive evidence for perioperative chemotherapy superiority over neoadjuvant chemoradiation in this disease setting.

UNICANCER PRODIGE GI Network

Led UNICANCER PRODIGE trial network conducting multicenter French gastric and esophageal cancer trials, generating substantial European evidence on chemotherapy regimens and biomarker-guided treatment selection.

Representative Works 代表性著作

[1]

Perioperative Chemotherapy with FLOT versus Preoperative Chemoradiation for Resectable Esophageal Cancer (ESOPEC)

New England Journal of Medicine (2024)

ESOPEC trial establishing FLOT superiority over CROSS in esophageal cancer.

[2]

FOLFOX versus FOLFIRI as First-Line Treatment in Gastric Cancer (PRODIGE 17)

Annals of Oncology (2019)

French PRODIGE gastric cancer randomized trial.

🏆Awards & Recognition 奖项与荣誉

🏆French Cancer Federation Research Award
🏆ESMO Upper GI Award for Excellence

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 米歇尔·迪克鲁 的研究动态

Follow Michel Ducreux's research updates

留下邮箱,当我们发布与 Michel Ducreux(Gustave Roussy Cancer Campus)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment